Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine

Chang Yi Wang(Asia University), T P Monath(Altimmune (United Kingdom)), Chwan-Chuen King King(Institute of Epidemiology, Disease Control and Research), Hsuan-Yu Shen(Asia University), Ming-Han Jiang(Asia University), Farshad Guirakhoo, Hope Liu(Asia University), Hui-Kai Kuo(Asia University), Tracy Kemp(Dallas VA Medical Center), Yu-Rou Lan(Asia University), Daphne Shen(PolymerPlus (United States)), Hui-Jiing Yu, Kao‐Pin Hwang(China Medical University), Mei Mei Hu(United Biomedical (United States)), Jennifer Cheng(Asia University), James Peng, Yi‐Ling Lin(Genomics Research Center, Academia Sinica), Hao‐Yu Shih(Asia University), Shuang Ding(Chinese Academy of Sciences), Jian‐Jong Liang(Institute of Biomedical Sciences, Academia Sinica), Huang-Ting Wu(Asia Centre), Carl V. Hanson(University of California, Berkeley), Michael Hellerstein(ExxonMobil (United States)), Yu‐Chi Chou(Institute of Biomedical Sciences, Academia Sinica), Mary Kate Morris(California Department of Public Health), Sky Chen(PolymerPlus (United States)), Yu-Hsin Ho(Asia University), Han C. Chiu(CTI BioPharma (United States)), Feng Lin(United Biomedical (United States)), Zhi Liu(Huazhong University of Science and Technology), Po-Yen Chang(Asia University), Ya-Ting Yang(Asia University), Juin-Hua Huang(Asia University), Donald Gray Heppner(United Biomedical (United States)), Min-Sheng Wang(Wuhan University), Be-Sheng Kuo(Asia University), Chun‐Che Liao(Institute of Biomedical Sciences, Academia Sinica), Kuo-Liang Hou(Asia University)
Research Square
October 18, 2021
Cited by 2


Related Papers